Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scalp Psoriasis”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Large-scale testing (Phase 3)Study completedNCT01195831
What this trial is testing

Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
LEO Pharma 244
Not applicableStudy completedNCT04801433
What this trial is testing

Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Xijing Hospital 240
Not applicableStudy completedNCT01202565
What this trial is testing

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506
Post-approval studies (Phase 4)Study completedNCT00791765
What this trial is testing

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Who this might be right for
Psoriasis
Amgen 124
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Early research (Phase 1)Study completedNCT03880357
What this trial is testing

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Sun Pharmaceutical Industries, Inc. 485
Large-scale testing (Phase 3)Study completedNCT00216827
What this trial is testing

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Who this might be right for
Psoriasis of Scalp
LEO Pharma 1,485
Post-approval studies (Phase 4)Study completedNCT05969223
What this trial is testing

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Who this might be right for
Genital PsoriasisScalp Psoriasis
AbbVie 214
Testing effectiveness (Phase 2)Study completedNCT02933528
What this trial is testing

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Post-approval studies (Phase 4)Study completedNCT02533973
What this trial is testing

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 951
Post-approval studies (Phase 4)Study completedNCT01707043
What this trial is testing

Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris

Who this might be right for
Plaque Psoriasis
Wake Forest University 20
Post-approval studies (Phase 4)Study completedNCT00881868
What this trial is testing

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Scalp Psoriasis
Galderma R&D 81
Testing effectiveness (Phase 2)Study completedNCT01914627
What this trial is testing

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Who this might be right for
Scalp Psoriasis
G. Pohl-Boskamp GmbH & Co. KG 90
Post-approval studies (Phase 4)Looking for participantsNCT05858632
What this trial is testing

Immune Spatial Features of Guselkumab Cutaneous Response

Who this might be right for
Psoriasis of Scalp
University of California, San Francisco 10
Testing effectiveness (Phase 2)Study completedNCT02413229
What this trial is testing

Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Testing effectiveness (Phase 2)Study completedNCT00007293
What this trial is testing

Scalp Psoriasis Treatment With a Fiber Optic Comb

Who this might be right for
Psoriasis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 30
Large-scale testing (Phase 3)Study completedNCT05028582
What this trial is testing

Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)

Who this might be right for
Scalp Psoriasis
Arcutis Biotherapeutics, Inc. 432
Early research (Phase 1)Study completedNCT03122353
What this trial is testing

BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis

Who this might be right for
Scalp Psoriasis
Tolmar Inc. 699
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Large-scale testing (Phase 3)Study completedNCT00279162
What this trial is testing

Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 160
Load More Results